184 In the index

Insulin degludec DEGL

A very long-acting insulin (Tresiba) approved for diabetes, giving steady coverage for more than a full day. Studies show more consistent day-to-day blood sugar control and somewhat fewer low-blood-sugar episodes than older long-acting insulins.

Also known as Tresiba

Effects Build muscle

Routes Subcutaneous

Legal status Prescription drug

WADA Banned at all times

Molecular Structure of C₂₇₄H₄₁₁N₆₅O₈₁S₆

Drag to rotate · scroll to zoom

PubChem has no 3D conformer for this molecule, so this is the flat structure.

Chemistry

Formula: C274H411N65O81S6
Molar mass: 6104
CAS: 844439-96-9
PubChem CID: 118984462

Reported dosing

Approved label

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Individualized, once-daily basal dosing (as prescribed)

Reported range Highly variable by patient

Route Subcutaneous injection

Frequency Once daily

Duration Chronic/ongoing (as prescribed)

FDA-approved ultra-long-acting basal insulin (Tresiba); same severe hypoglycemia risk applies to any non-medical use.

Where this comes from FDA prescribing information

These figures are recorded for reference and are not a recommendation. Dosing is a decision for you and a clinician.